Elhadj Djeriou

A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study

James McCarthy, Thomas Rückle, Elhadj Djeriou et al. · Malaria Journal · 2016 · 125 citations · Full text

Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study

Jana Held, Christian Supan, Carmen L. Ospina Salazar et al. · The Lancet Infectious Diseases · 2015 · 88 citations

Global Health, Malaria, Clinical Epidemiology +6

Liver Enzyme Elevations in Plasmodium falciparum Volunteer Infection Studies: Findings and Recommendations

Mohamed Farouk Chughlay, Samantha Akakpo, Anand Odedra et al. · American Journal of Tropical Medicine and Hygiene · 2020 · 32 citations · Full text

Phase 2a, Open-Label, 4-Escalating-Dose, Randomized Multicenter Study Evaluating the Safety and Activity of Ferroquine (SSR97193) Plus Artesunate, versus Amodiaquine Plus Artesunate, in African Adult Men with Uncomplicated Plasmodium falciparum Malaria

Christian Supan, Ghyslain Mombo‐Ngoma, Maryvonne Kombila et al. · American Journal of Tropical Medicine and Hygiene · 2017 · 29 citations · Full text

Randomized, open-label, phase 2a study to evaluate the contribution of artefenomel to the clinical and parasiticidal activity of artefenomel plus ferroquine in African patients with uncomplicated Plasmodium falciparum malaria

Adama Gansané, Moussa Lingani, Adoke Yeka et al. · Malaria Journal · 2023 · 16 citations · Full text